ANTH Recent News Global Systemic Lupus Erythemato
Post# of 57
Global Systemic Lupus Erythematosus and Lupus Nephritis Drug Forecast and Market Analysis to 2022 M2 - Thu Feb 27, 4:59AM CST
Lupus Nephritis Global Clinical Trials Review, H1, 2014 Research Report M2 - Mon Feb 24, 3:18AM CST
Nephropathy - Pipeline Review, H2 2013 Report Available Now M2 - Fri Feb 14, 3:12AM CST
Thirty-Eight Percent of Workers Have Dated a Co-Worker, Finds CareerBuilder Survey PR Newswire - Thu Feb 13, 5:00AM CST
Anthera Pharmaceuticals to Present at Leerink Swann, Cowen & Co., and BIO CEO Healthcare Conferences PR Newswire - Thu Jan 30, 3:42PM CST
PSM Holdings, Inc. (PSMH) Announces Additions to its Approved States List PR Newswire - Thu Jan 30, 8:00AM CST
FLG Partners Announces Chris Lowe as a New Partner Marketwire - Tue Jan 28, 12:09PM CST
Flowserve Announces New Mobile Device App for Gestra Products Thomson Reuters ONE - Thu Jan 09, 6:06PM CST
Blisibimod (Systemic Lupus Erythematosus and Lupus Nephritis) - Forecast and Market Analysis to 2022 M2 - Wed Dec 11, 9:08AM CST
Anthera Pharmaceuticals to Present at Annual Piper Jaffray Healthcare Conference PR Newswire - Wed Nov 27, 4:00PM CST